Choong Ang Vaccine Laboratory Co. Ltd (072020) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.022x

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has a cash flow conversion efficiency ratio of 0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.30 Billion ≈ $1.56 Million USD) by net assets (₩106.81 Billion ≈ $72.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Choong Ang Vaccine Laboratory Co. Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Choong Ang Vaccine Laboratory Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Raonsecure Co. Ltd KQ:042510	-0.015x
Evertex Fabrinology Ltd TW:1470	0.041x
Kredyt Inkaso SA WAR:KRI	0.105x
PUBLIC POLICY HO.COM 144A F:PD7	N/A
Byuksan Corp KO:007210	0.012x
Ama Marine Public Company Limited BK:AMA	0.047x
China Tianrui Group Cement Company Limited F:T18	0.021x
Glomac Bhd KLSE:5020	-0.010x

Annual Cash Flow Conversion Efficiency for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Choong Ang Vaccine Laboratory Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩105.37 Billion ≈ $71.41 Million	₩7.87 Billion ≈ $5.33 Million	0.075x	-42.10%
2024-12-31	₩103.87 Billion ≈ $70.39 Million	₩13.40 Billion ≈ $9.08 Million	0.129x	+1.35%
2023-12-31	₩99.80 Billion ≈ $67.64 Million	₩12.71 Billion ≈ $8.61 Million	0.127x	+71.24%
2022-12-31	₩95.30 Billion ≈ $64.59 Million	₩7.09 Billion ≈ $4.80 Million	0.074x	-40.02%
2021-12-31	₩92.98 Billion ≈ $63.01 Million	₩11.53 Billion ≈ $7.81 Million	0.124x	+30.51%
2020-12-31	₩87.55 Billion ≈ $59.33 Million	₩8.32 Billion ≈ $5.64 Million	0.095x	-1.15%
2019-12-31	₩86.37 Billion ≈ $58.53 Million	₩8.30 Billion ≈ $5.62 Million	0.096x	+43.06%
2018-12-31	₩85.00 Billion ≈ $57.61 Million	₩5.71 Billion ≈ $3.87 Million	0.067x	-42.55%
2017-12-31	₩64.68 Billion ≈ $43.83 Million	₩7.56 Billion ≈ $5.12 Million	0.117x	-8.46%
2016-12-31	₩60.37 Billion ≈ $40.91 Million	₩7.71 Billion ≈ $5.23 Million	0.128x	-29.41%
2015-12-31	₩54.88 Billion ≈ $37.19 Million	₩9.93 Billion ≈ $6.73 Million	0.181x	+41.03%
2014-12-31	₩51.99 Billion ≈ $35.23 Million	₩6.67 Billion ≈ $4.52 Million	0.128x	--

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$61.71 Million

₩91.06 Billion KRW

Market Cap Rank

#21129 Global

#1201 in Korea

Share Price

₩9730.00

Change (1 day)

+0.62%

52-Week Range

₩8780.00 - ₩10140.00

All Time High

₩30815.73